nexbetsports 1
The Land Broker Co-op Celebrates the Successful Conclusion of the Third Annual National Land Investment Month
Resolution of Non-Compliance with the NYSE RulesKing and PM honour former US president Jimmy Carter after his death aged 100
It's beginning to look like another record for holiday travelElectrolyzer – McPhy and the University of Florence (UNIFI) sign a joint laboratory & research partnership agreement
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Slack will deeply integrate Salesforce’s Agentforce AI agents into its workplace collaboration platform, emphasizing contextual intelligence as the key differentiator in the increasingly crowded AI agent market. “There’s so much of your organization’s knowledge context, what’s important... Slack’s channels typically reflect your organization’s structure, but also your priorities for that given moment,” said Rob Seaman, Slack’s Chief Product Officer, in an exclusive interview with VentureBeat. “That is just such rich context for agents to be able to answer questions and reason through whether or not they need to be able to take action.” Why context matters for enterprise AI The integration, part of Salesforce’s Agentforce 2.0 launch scheduled for tomorrow, December 17th, aims to make AI agents more effective by giving them access to the vast troves of conversational and organizational data that flow through Slack’s channels daily. Seaman outlined three critical capabilities that define these next-generation AI agents: comprehensive contextual knowledge, reasoning ability, and action-taking power. What sets Slack’s implementation apart is its unique position as what Seaman calls a “searchable log of all communication and knowledge” — effectively making it the central nervous system of modern enterprises. Inside Slack’s new AI agent library The platform will introduce a library of customizable AI agents that can perform various tasks, from onboarding new employees to managing complex cross-functional projects. “You’ll see the library of agents in Slack. And it’s pretty magical to see humans and agents together, and to think of this world where humans continue to work with humans, but agents are there as part of the team,” Seaman explained. A key focus is user trust and data governance. Seaman emphasized that all agents will operate with “user context,” meaning they can only access information that the user has permission to see. “Our goal ultimately is to honor user context for every system that an agent and a person has interacted with,” he said. The platform includes robust safeguards through what Salesforce calls a “ trust layer ,” which handles sensitive information appropriately and ensures compliance with business rules. Users can test agents in real-time and observe their decision-making processes through a transparent builder interface. How AI agents could transform enterprise software For enterprises struggling with fragmented software stacks, this integration could signal a shift in how organizations approach their technology infrastructure. While Seaman avoided specific predictions about which tools might become obsolete, he suggested that many manual processes currently “spaghetti-ed across numerous systems” could be streamlined through these contextually-aware agents. One concrete example Seaman highlighted was employee onboarding: “Taking you from like new hire to productive, is something that the company cares about, and it’s also, from an end user perspective, it’s kind of a lonely, like, scary experience in your first several months as you’re, like, trying to find your way.” The race for enterprise AI dominance The integration represents a strategic move by both Slack and Salesforce to position themselves at the forefront of the enterprise AI revolution. While companies like Anthropic and OpenAI have launched their own AI agents, Slack’s deep integration with enterprise workflows and access to organizational context could provide a significant competitive advantage. The development comes at a crucial time as organizations grapple with how to effectively implement AI tools while maintaining security and trust. With this launch, Slack and Salesforce are betting that contextually-aware AI agents, deeply integrated into existing workflows, will prove more valuable than standalone AI solutions. The question remains whether enterprises will embrace this vision of AI agents as team members, but with Slack’s widespread adoption in modern workplaces, the platform is well-positioned to drive this transformation. As Seaman notes, “We’re pretty lucky, frankly, that we’re in this moment, and we have a lot of the primitives that are required to make this possible.” If you want to impress your boss, VB Daily has you covered. We give you the inside scoop on what companies are doing with generative AI, from regulatory shifts to practical deployments, so you can share insights for maximum ROI. Read our Privacy Policy Thanks for subscribing. Check out more VB newsletters here . An error occured.Indianapolis Colts coach Shane Steichen seemed to sense the question might arise after his club was eliminated from playoff consideration Sunday with a ghastly 45-33 loss to the host New York Giants in East Rutheford, N.J. The Giants were 2-13 and had lost a franchise-record 10 straight games entering the contest and their season-high point total Sunday more than tripled their season average of 14.3 points per game. It was the type of bad loss that leads to head coaches being asked about their job security. "I control what I can control," Steichen said of the employment situation. The Colts (7-9) were outplayed all contest by the team that entered the day with the worst record in the NFL -- and with their playoff hopes on the line. Last season, Steichen's first as Indianapolis coach, the Colts also fell short, losing to the Houston Texans in the final week of the season to miss the playoffs. "It was as disappointing as it gets," Steichen said of the setback against the Giants. "As the leader of a football team, shoot, I always say I've got to be better, we've all got to be better. That's a group effort, everyone's got to chip in and do their part, so stuff like that doesn't happen." Giants quarterback Drew Lock passed for 309 yards and tied his career high of four touchdowns while also running for a score. Meanwhile, the Colts also went with a reserve quarterback in veteran Joe Flacco and he turned the ball over three times on two interceptions and a fumble. He also passed for 330 yards. Flacco started because rookie Anthony Richardson couldn't play due to back and foot injuries. Indianapolis completes the season next weekend at home against the Jacksonville Jaguars. "I know it's a tough situation, obviously, when you're out of the playoff hunt, but again, I told (the team) we've got to be professional about it," Steichen said. "That's the biggest thing. We've got to show up and do our job still with one week left." The Colts last made the playoffs in the 2020 season. Their last playoff win was two seasons earlier. --Field Level Media
NASHUA, N.H., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Further to a release issued under the same headline on November 26, 2024 13:00 ET by iCAD, Inc., the headline and fourth paragraph have been updated to acknowledge a pending trademark application for the mark “SecondReadAI” by Lunit, Inc. The corrected release follows: iCAD, Inc . (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI-driven breast health solutions. iCAD and Cascaid Health Partner to Expand Access to AI-Driven Breast Health In alignment with their vision to enable all women to access to AI-powered breast health services, iCAD and Cascaid Health will unveil their collaboration to integrate the ProFound AI Breast Health Suite into Cascaid’s leading edge digital health marketplace and access to care platform. Scheduled for beta launch in Q1 2025, this partnership between iCAD and Cascaid Health will launch ProFound Health, a virtual care model powered by Cascaid. ProFound Health will enable women who have not otherwise received an AI-read on their screening mammogram to access iCAD’s advanced breast health technology. The initiative reflects both companies’ dedication to democratizing access to life-saving technology and creating a world where cancer can’t hide. ProFound Health partnership will offer virtual second reads of mammograms leveraging ProFound AI Breast Health Suite, an AI service providing patients without access to AI an opportunity to receive enhanced breast health insights. The initial service will include a second read detection, breast density assessment, and cancer risk evaluation from a Cascaid-affiliated specialist network of clinical experts in women’s health through Cascaid’s seamlessly integrated digital platform. By combining AI insights with expert clinical reviews, ProFound Health ensures that patients everywhere, regardless of location, can receive precision screening and personalized care. “ProFound Health empowers patients with access to critical information about their mammograms and overall breast health, allowing them to make informed decisions and take control of their care journey,” said Dana Brown, CEO and President of iCAD. “Our collaboration with Cascaid Health’s network of clinicians and AI-powered solutions is part of our ongoing commitment to bridging gaps in breast cancer care, ensuring all patients everywhere can access the accuracy and timeliness of AI solutions, and ultimately transforming patient outcomes.” “We believe that every woman should have access to the best possible information about her breast health and a high quality, personalized care plan to catch cancer early or prevent it altogether. Through our partnership with iCAD, we’re addressing a critical need to improve access to advanced breast health services,” said Dr. Candace Westgate, Director of Women’s Health for Cascaid Health. “ProFound Health is more than just a technological innovation, it’s a lifeline that empowers patients and healthcare providers with actionable insights, bridging care gaps and ensuring equitable access to precision screening and personalized breast cancer care.” Advancing Next Generation AI Breast Health Solutions at RSNA 2024 In addition to ProFound Health, iCAD will feature its flagship ProFound Detection Version 4.0, which recently received FDA clearance. This next-generation AI solution enhances breast cancer detection by incorporating prior exams into current analysis, improving the detection of aggressive cancers by 22%, reducing cases with no marks by 18%, and providing clinicians with more reliable insights for better decision-making. “Every two minutes, someone loses their life to breast cancer—a disease affecting over 2.3 million women annually. Early detection is critical, as five-year survival rates exceed 99% for stage 1 disease. Yet traditional mammography misses over 20% of breast cancers, particularly in dense tissue, resulting in potentially avoidable late-stage diagnoses,” said Dana Brown, President and CEO of iCAD, Inc. “ProFound Detection Version 4 revolutionizes breast cancer detection by uniquely integrating prior exams into its analysis. This advanced capability enhances sensitivity, sharpens precision, and provides radiologists with a deeper, longitudinal view of a patient’s breast health. By enabling earlier and more accurate detection, especially in dense tissue, ProFound Detection Version 4 sets a new standard in breast health AI, empowering providers to improve outcomes and save lives. Together with our strategic partnerships, we are advancing the fight against cancer and making a meaningful difference for patients worldwide.” ICAD’S RSNA 2024 Program Highlights AI-Powered Insights: Advancing Cancer Detection Oral Abstract Presentation : “Real World Effect of Artificial Intelligence on Histopathology and Stage in Breast Cancer Screening” Presenter : Kathy Schilling, M.D., Boca Raton Regional Hospital When : Sunday, December 1 | 10:30–11:30 AM Where : S406A: S2-SSBR01-6 Details : Dr. Kathy Schilling discusses the experience with tenured radiologists on how the current use of ProFound AI improves cancer detection, even in women with dense breast tissue, compared to their performance prior to the implementation of AI. In addition, she will describe the decrease in the mean size and stage of cancers after the implementation, along with an increase in the diagnosis of lobular cancers. “The integration of ProFound AI alongside our nine dedicated breast radiologists has demonstrated remarkable improvements in cancer detection and patient outcomes across our imaging network,” said Dr. Kathy Schilling, Medical Director of the Christine E. Lynn Women’s Health & Wellness Institute at Boca Raton Regional Hospital. “We’ve seen a 23% overall increase in cancer detection rates, a 4% rise in invasive cancer detection, and doubled rates of lobular cancer detection. ProFound AI also enhanced detection in dense breast tissue by 32%, reduced invasive cancer size by 12%, and lowered histopathologic stage with a 40% reduction in T2 tumors—all without increasing DCIS diagnoses or recall rates. These advancements underscore the transformative potential of AI in improving early breast cancer detection, elevating patient care, and ultimately saving lives.” AI Theater Presentation : “The Thin White Line: Which Calcifications Matter? Advances in AI Breast Cancer Detection” Presenter : Chirag R. Parghi, M.D., M.B.A., Solis Mammography When : Tuesday, December 3 | 1:00–1:20 PM Where : AI Showcase Theater (South Hall A), Booth 5536 Details : A look at how ProFound Detection’s next-generation capabilities reduce uncertainty in interpreting calcifications on a mammogram by displaying 20% fewer marks related to vascular calcifications and 51% fewer marks related to non-vascular calcifications, leading to enhanced precision and accuracy. Collaborative Panels and Partner Showcases GE HealthCare Expert Corner : Seamless integration of ProFound AI with GE mammography systems to enhance workflow and detection capabilities. Daily at Booth 7330 (North Hall). Densitas Panel : “Elevating Patient Care through Quality Images & Precise Detection.” Daily at Booth 4747 (South Hall). CancerIQ : Daily at Booth 4747(South Hall). Blackford Panel : “Enhancing Breast Cancer Care with AI.” Tuesday, December 3, 2:30-2:50 PM at Booth 4729 (South Hall). CARPL.ai Breast AI Panel : Wednesday, December 4, 11:00 AM at Booth 5733 (South Hall). Customer Appreciation Event iCAD will be hosting a customer appreciation event, "AI in the Sky: Discover ProFound Insights & Breast Health Innovations," on Sunday, December 1, at 6:00 PM at VU Rooftop in Chicago. Network with industry experts, hear insights from key opinion leaders including iCAD’s CEO and Board of Directors, and explore how iCAD’s solutions are transforming breast health. Visit the iCAD RSNA 2024 event page for the latest updates, event details, and partnership announcements. About Cascaid Health Cascaid Health Inc. delivers a personalized, expert-driven proactive and preventative approach, supported by an integrated platform designed to promote longevity, detect issues early, reverse risks, and optimize healthspan for all. The company’s platform offers a curated marketplace featuring innovative products, services, and access to world-class multidisciplinary experts in women’s health, precision health, lifestyle medicine, wellness, and performance. Cascaid Health Inc. is committed to advancing health equity, ensuring that cutting-edge healthcare solutions are accessible to everyone. About iCAD, Inc. iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes. Headquartered in Nashua, N.H., iCAD’s industry-leading ProFound Breast Health Suite provides AI-powered mammography analysis for breast cancer detection, density assessment and risk evaluation. Used by thousands of providers serving millions of patients, ProFound is available in over 50 countries. In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, with nearly 30% being tomosynthesis. For more information, including the latest in regulatory clearances, please visit www.icadmed.com . Forward-Looking Statements Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expansion of access to the Company’s products, improvement of performance, acceleration of adoption, expected benefits of ProFound AI®, the benefits of the Company’s products, and future prospects for the Company’s technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company’s ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe,” “demonstrate,” “intend,” “expect,” “estimate,” “will,” “continue,” “anticipate,” “likely,” “seek,” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at https://www.icadmed.com and on the SEC’s website at http://www.sec.gov . CONTACTS Media Inquiries: pr@icadmed.com Investor Inquiries: John Nesbett/Rosalyn Christian IMS Investor Relations icad@imsinvestorrelations.com
Grow Clinton recognizes Nestle Purina Petcare with Spotlight Innovation AwardAfter a rocky start, PM sets out ‘next phase’ covering economic growth, NHS backlogs, energy, and a ‘bobby on every beat’, the 20-year-old guard, has faced more than just the pressure of following in his father's footsteps during his first months as a professional basketball player. According to the AP, eldest son recently shared the ongoing he's working through following his in July 2023. Bronny James opens up about mental health , while sharing the spotlight with his father on the , has struggled to be productive on the court. made headlines last year after suffering a cardiac arrest at 19. "Trying to get past that... It's difficult, but I'm trying to work at it every day," admitted, reflecting on the toll the health scare has taken on his mental well-being. His sudden collapse during a practice at not only disrupted his freshman season but also caused his draft stock to drop significantly. Originally expected to be a lottery pick, was ultimately selected 55th overall by the Lakers in the 2024 draft. Despite the setback, perspective remains optimistic. Bronny James resilience showcased in the G League While his debut has been quiet, with modest stats of 0.6 points, 0.1 rebounds, and 0.3 assists, has shown promise in the . In seven games with the , he's averaged 13.4 points, 3.0 rebounds, and 3.4 assists, including a career-high 30 points on December 12. said, emphasizing his focus on continuous improvement. His recent performances have sparked reactions from fans, with many expressing their support for his journey. On Saturday, delivered one of his best games yet, posting 23 points, nine rebounds, and five assists in a close loss to the . His father, , proudly shared his son's performance on social media, alongside the unwavering support of his mother, . Despite the challenges, resilience on and off the court continues to inspire those following his path.